Letters sent to healthcare professionals in July 2017

Source:
GOV UK
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
15 August 2017

Abstract

Letters were sent about ibrutinib, daclizumab, aflibercept, valproate medicines, and arsenic trioxide.